Press Releases
August 3, 2022
Surface Oncology Reports Financial Results and Business Highlights for Second Quarter 2022
August 1, 2022
Surface Oncology to Participate in the 2022 Wedbush PacGrow Healthcare Conference
June 29, 2022
Surface Oncology Appoints Carsten Brunn to Board of Directors
June 20, 2022
Surface Oncology Announces Publication of New Study Demonstrating the Role of the IL-27 Pathway in Hepatocellular Carcinoma
June 3, 2022
Surface Oncology Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 1, 2022
Surface Oncology to Participate in Upcoming Investor Conferences
May 26, 2022
Surface Oncology to Present New SRF388 Clinical Data at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
May 17, 2022
Surface Oncology to Participate in Upcoming Investor Conferences
May 9, 2022
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2022
May 6, 2022
Surface Oncology Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Displaying 1 - 10 of 20